All News

Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.

January 24, 2017

Pharm Exec is back at the 2017 J.P. Morgan Healthcare Conference in San Francisco, CA.

The seven ways for pharmas to ensure successful execution of action steps following brand "war games."

Click the title above to open the Pharmaceutical Executive January 2017 issue in an interactive PDF format.

Anthony Arnold offers an overview and update of bioelectronic medicine.

That may be one option as the UK agency, like the NIH it supports, looks at how to generate big savings.

“Volume is not a dirty word” was outgoing GSK head Sir Andrew Witty’s key message at last week’s FT Global Pharmaceutical Conference in London.

This year’s 19th annual European Health Forum Gastein (Austria) once again attempted to establish unity in the face of EU woes. But are the Gastein region’s “healing powers” on the wane?

Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.

Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.

PDUFA VI to enhance FDA staffing, revise fees and expand evidence for drug development.

Click the title above to open the Pharmaceutical Executive October 2016 issue in an interactive PDF format.

Emma Walmsley will succeed Andrew Witty next year and become the seventh female chief executive in the FTSE 100.

Click the title above to open the Pharmaceutical Executive September 2016 issue in an interactive PDF format.

A look at the EU plans for a European patent, and where the UK fits in the mix.

The chances are slim, but a new resolution in Europe on the subject could drum up support for a Brexit-like scenario.

Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.

July 22, 2016

Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.

In the healthcare industry, “patient centricity” is like comfort food – everyone knows what it is, but it can mean very different things to different people.

In this paper, we’ll explore opportunities pharma marketers have to create engaging experiences that will deliver new types of value to meet their targets’ evolving expectations.